Hazer Group Valuation

Is HZR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of HZR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate HZR's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate HZR's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for HZR?

Key metric: As HZR is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for HZR. This is calculated by dividing HZR's market cap by their current revenue.
What is HZR's PS Ratio?
PS Ratio	24.6x
Sales	AU$3.32m
Market Cap	AU$83.99m

HZR key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	21.5x
Enterprise Value/EBITDA	-4.5x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does HZR's PS Ratio compare to its peers?

The above table shows the PS ratio for HZR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	10x
CLV Clover	1.3x	11.9%	AU$78.5m
DGL DGL Group	0.3x	8.1%	AU$156.9m
ANO Advance ZincTek	4.8x	n/a	AU$47.5m
TTT Titomic	33.6x	n/a	AU$246.8m
HZR Hazer Group	24.6x	57.5%	AU$84.0m

Price-To-Sales vs Peers: HZR is expensive based on its Price-To-Sales Ratio (24.6x) compared to the peer average (10x).

Price to Sales Ratio vs Industry

How does HZR's PS Ratio compare vs other companies in the AU Chemicals Industry?

14 Companies	Price / Sales	Estimated Growth	Market Cap
ORI Orica	1.2x	4.0%	US$5.72b
IPL Incitec Pivot	1.1x	0.7%	US$3.86b
NUF Nufarm	0.5x	7.6%	US$1.02b
DGL DGL Group	0.3x	8.1%	US$102.00m

14 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: HZR is expensive based on its Price-To-Sales Ratio (24.6x) compared to the Australian Chemicals industry average (4.8x).

Price to Sales Ratio vs Fair Ratio

What is HZR's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HZR PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	24.6x
Fair PS Ratio	38x

Price-To-Sales vs Fair Ratio: HZR is good value based on its Price-To-Sales Ratio (24.6x) compared to the estimated Fair Price-To-Sales Ratio (38x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Incitec Pivot

AU$5.9b

Manufactures and distributes industrial explosives, industrial chemicals, and fertilizers in Australia and the United State.

IPL

AU$3.15

4.8%

10.2%

Capral

AU$160.0m

Manufactures, markets, and distributes fabricated and semi-fabricated aluminum related products in Australia.

CAA

AU$9.19

-2.9%

5.1%

Nufarm

AU$1.6b

Develops, manufactures, and sells crop protection solutions and seed technologies in Europe, the Middle East, Africa, North America, and the Asia Pacific.

NUF

AU$4.07

4.9%

-11.5%